by MEGIN | Nov 21, 2019 | MEGIN News
HELSINKI, FINLAND (NOVEMBER 21, 2019) – Arkansas Children’s Hospital is now home to the TRIUX™ neo, the first and only magnetoencephalography system (MEG) in Arkansas. The TRIUX™ neo is MEGIN’s next generation of MEG technology which is used to detect and...
by MEGIN | Oct 9, 2019 | MEGIN News
HELSINKI, FINLAND (OCTOBER 9, 2019) – MEGIN is pleased to announce the sale of our fourth-generation technology, the TRIUX™ neo, to three internationally renowned neuroscience facilities. We are looking forward to working with the MRC Cognition and Brain Sciences Unit...
by MEGIN | Dec 6, 2018 | MEGIN News
MEGIN CEO Speaks at Neuroscience-20 World Brain Mapping Summit in Argentina BUENOS AIRES, Argentina, Dec. 6, 2018 — Janne Huhtala, CEO of MEGIN, a manufacturer of magnetoencephalography (MEG) technology for functional brain imaging, spoke about the future...
by MEGIN | Sep 26, 2018 | MEGIN News
Click here to see the entire original article. “MEMPHIS, Tenn., Sept. 26, 2018/PRNewswire/ –MEGIN announced today Le Bonheur Children’s Hospital is the first hospital in the world to install TRIUX™ neo, the next generation of...
by MEGIN | Feb 18, 2018 | MEGIN News
OXFORD, UNITED KINGDOM (February 08, 2019) – MEGIN is pleased to announce that the University of Oxford is the first in Europe to acquire the latest technology in functional brain imaging. TRIUX™ neo, a magnetoencephalograph (MEG), is a highly sensitive non-invasive...
